| Alexander J Harmatz, MD | |
|
10 Presidential Blvd, Suite 124, Bala Cynwyd, PA 19004-1107 | |
| (610) 664-9700 | |
| (610) 664-6391 |
| Full Name | Alexander J Harmatz |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 40 Years |
| Location | 10 Presidential Blvd, Bala Cynwyd, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730142696 | NPI | - | NPPES |
| 0001414183 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD045117L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Our Lady Of Fatima Hospital | North providence, RI | Hospital |
| Roger Williams Medical Center | Providence, RI | Hospital |
| The Miriam Hospital | Providence, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prospect Chartercare Physicians Llc | 0840416657 | 83 |
News Archive
RadNet, Inc., a national leader in providing high-quality, fixed-site outpatient diagnostic imaging services through a network of 180 imaging centers, today announced the pricing of its offering of $200 million in aggregate principal amount of 10⅜% senior notes due 2018 at an issue price of 98.680%.
Cabozantinib, a drug already used to treat patients with certain types of thyroid or kidney cancer, was able to eradicate invasive prostate cancers in mice by causing tumor cells to secrete factors that entice neutrophils - the first-responders of the immune system - to infiltrate the tumor, where they triggered an immune response that led to tumor clearance.
pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has submitted a New Drug Application to the U.S. Food and Drug Administration for Iluvien for Diabetic Macular Edema.
Researchers at Fred Hutchinson Cancer Research Center have received a $7.6 million, four-year grant from the National Human Genome Research Institute to better understand the genetic and biological roots of common diseases. The Hutchinson Center is one of four U.S. research institutes to receive grants totaling about $31 million toward this effort.
URAC today announced a call for public comment on the second set of toolkits for its new Patient Centered Health Care Home (PCHCH) Program. The program, comprised of an integrated series of three educational toolkits, will help health care practices follow a step-wise process in their journey to becoming a PCHCH.
› Verified 3 days ago
| Entity Name | Prospect Chartercare Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629493135 PECOS PAC ID: 0840416657 Enrollment ID: O20140730001883 |
News Archive
RadNet, Inc., a national leader in providing high-quality, fixed-site outpatient diagnostic imaging services through a network of 180 imaging centers, today announced the pricing of its offering of $200 million in aggregate principal amount of 10⅜% senior notes due 2018 at an issue price of 98.680%.
Cabozantinib, a drug already used to treat patients with certain types of thyroid or kidney cancer, was able to eradicate invasive prostate cancers in mice by causing tumor cells to secrete factors that entice neutrophils - the first-responders of the immune system - to infiltrate the tumor, where they triggered an immune response that led to tumor clearance.
pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has submitted a New Drug Application to the U.S. Food and Drug Administration for Iluvien for Diabetic Macular Edema.
Researchers at Fred Hutchinson Cancer Research Center have received a $7.6 million, four-year grant from the National Human Genome Research Institute to better understand the genetic and biological roots of common diseases. The Hutchinson Center is one of four U.S. research institutes to receive grants totaling about $31 million toward this effort.
URAC today announced a call for public comment on the second set of toolkits for its new Patient Centered Health Care Home (PCHCH) Program. The program, comprised of an integrated series of three educational toolkits, will help health care practices follow a step-wise process in their journey to becoming a PCHCH.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexander J Harmatz, MD 10 Presidential Blvd, Suite 124, Bala Cynwyd, PA 19004-1107 Ph: (610) 664-9700 | Alexander J Harmatz, MD 10 Presidential Blvd, Suite 124, Bala Cynwyd, PA 19004-1107 Ph: (610) 664-9700 |
News Archive
RadNet, Inc., a national leader in providing high-quality, fixed-site outpatient diagnostic imaging services through a network of 180 imaging centers, today announced the pricing of its offering of $200 million in aggregate principal amount of 10⅜% senior notes due 2018 at an issue price of 98.680%.
Cabozantinib, a drug already used to treat patients with certain types of thyroid or kidney cancer, was able to eradicate invasive prostate cancers in mice by causing tumor cells to secrete factors that entice neutrophils - the first-responders of the immune system - to infiltrate the tumor, where they triggered an immune response that led to tumor clearance.
pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has submitted a New Drug Application to the U.S. Food and Drug Administration for Iluvien for Diabetic Macular Edema.
Researchers at Fred Hutchinson Cancer Research Center have received a $7.6 million, four-year grant from the National Human Genome Research Institute to better understand the genetic and biological roots of common diseases. The Hutchinson Center is one of four U.S. research institutes to receive grants totaling about $31 million toward this effort.
URAC today announced a call for public comment on the second set of toolkits for its new Patient Centered Health Care Home (PCHCH) Program. The program, comprised of an integrated series of three educational toolkits, will help health care practices follow a step-wise process in their journey to becoming a PCHCH.
› Verified 3 days ago
Marjorie Friedman, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 225 E City Ave Ste 109, Bala Cynwyd, PA 19004 Phone: 215-503-3838 | |
Dr. Jonathan L. Gelfand, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 205 Rhyle Ln, Bala Cynwyd, PA 19004 Phone: 215-805-5413 Fax: 610-672-9532 | |
Timothy A Woods, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 333 E City Ave, Suite Il -40, Bala Cynwyd, PA 19004 Phone: 610-664-1977 Fax: 610-667-6052 | |
Daniel H. Parish, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 50 Monument Road, Third Floor Suite 301, Bala Cynwyd, PA 19004 Phone: 610-668-2570 Fax: 610-668-2808 | |
Dr. Robert Weiss, M D Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: Total Access Medical, 191 Presidential Blvd C135, Bala Cynwyd, PA 19004 Phone: 610-667-7203 Fax: 610-667-0447 | |
Alexandra Marie Ristow, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 150 Monument Rd Ste 500, Bala Cynwyd, PA 19004 Phone: 855-478-8208 | |
Dr. Mary Van Den Berg-wolf, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 225 E City Ave, Suite 109, Bala Cynwyd, PA 19004 Phone: 215-503-3838 |